“…MRI, because of its noninvasive nature and high anatomical resolution, is being applied in a number of novel ways for determining CBF. One approach uses direct 2 H (1,2), 19 F (3-6), or 17 O (7-11) MR spectroscopy (MRS) or imaging to trace nonradioactive, exogenous markers (e.g., 2 H 2 O, CH 19 F 3 , and H 2 17 O) and quantify CBF from the time-dependent tracer concentration. While MRS offers superior tracer specificity and sensitivity, it has limited spatial resolution.…”